期刊文献+

地高辛血清浓度影响因素及我院合理应用情况分析 被引量:14

Analysis on Influence Factors of Plasma Concentration of Digoxin and Its Rational Use in Our Hospital
原文传递
导出
摘要 目的:探讨影响地高辛血清浓度(SDC)的因素及我院应用现状,为临床提高地高辛的合理应用比例提出建议。方法:收集2008~2009年我院445名住院患者581例/次服用地高辛并测定血清浓度的临床资料。分析我院目前地高辛应用的现状,应用多元逐步回归法分析年龄(Age)、性别(Gen)、科室(Dept)、合并用药(Drug)、血清肌酐浓度(Scr)、服药剂量(Dose)与SDC的关系。结果:Age、Gen、Dept、Drug、Scr、Dose与SDC有相关性。结论:SDC个体差异较大,影响因素较多。调查中16.2%服用地高辛患者出现不良反应,胃肠道反应最常见,对于其引起的心律失常不良反应应该引起足够的重视。我院外科住院患者SDC相对内科患者高(P<0.05)。对于大多数患者而言,每日用药剂量不宜>0.125mg。老年女性患者应用地高辛尤应注意用药剂量,及时监测。药师在地高辛的合理用药中应发挥更多的作用。 OBJECTIVE:To investigate the influence factors of plasma concentration of digoxin(SDC)and application of it in our hospital in order to promote rational use of digoxin. METHODS:445 cases treated with digoxin were collected from our hospital and plasma concentration of digoxin was detected. Multiple stepwise regressions were used to analyze current application of digoxin,relationship between SDC and factors including age,gender(Gen),departments(Dept),drug combination(Drug),serum creatinine concentration(SCR),dose. RESULTS:SDC was relation with age,gender(Gen),departments(Dept),drug combination(Drug),serum creatinine concentration(SCR),dose. CONCLUSION:There are many influence factors of SDC which are different among individual patients. In our survey,16.2% patients taking digoxin occurs adverse reactions. The most common adverse reaction is nausea and poor appetite. We should pay attention to arrhythmia caused by digoxin. The SDC of surgical inpatients were higher than that of medical inpatients(P0.05). For most patients,daily dose of digoxin should be lower than 0.125 mg. Elderly female patients taking digoxin should care dosage and to be monitored timely. Pharmacist should play a greater role in the application of digoxin.
出处 《中国药房》 CAS CSCD 北大核心 2010年第16期1514-1517,共4页 China Pharmacy
关键词 地高辛 血清浓度 合理用药 Digoxin Serum concentration Rational drug use
  • 相关文献

参考文献11

  • 1The Digitalis Investigation Group (DIG) .The effect of digoxin on mortality and morbidity in patients with heart failure[J]. NEngl J Med, 1997, 336(8): 525.
  • 2杨藻宸.医用药理学[M].北京:人民卫生出版社,2005.700.
  • 3国家药典委员会.中华人民共和国药典·临床用药须知(化学药和生物制品卷)[S].2005年版.北京:人民卫生出版社,2005:694-695.
  • 4Rathore SS, Curtis JP, Wang Y, et al. Association of serum digoxin concentration and outcomes in patients with heart failure [J]. JAMA, 2003,289 (7) :871.
  • 5Digitalis Investigation Group, Ahmed A, Waagstein F, et al. Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial[J]. Am J Cardiol, 2009,103 ( 1 ) : 82.
  • 6白玉国,张爱琴,张沫,刘翎,王海燕,郑清敏.影响血清地高辛浓度因素的调查分析[J].药物不良反应杂志,2006,8(5):342-346. 被引量:10
  • 7Slatton ML, Irani WN, Hall SA, et al. Dose digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure innormal sinusrhythrn[J]. Am J Coll Cardiol, 1997,29(6): 1 206.
  • 8Shlipak MG, Smith GL, Rathore SS, et al. Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial[J]. Am Soc Nephrol, 2004, 15(8): 2 195.
  • 9田应彪,陈泽慧,程昌华,汪世明,王敏,何勇.我院地高辛血药浓度监测结果分析[J].中国药房,2008,19(17):1319-1320. 被引量:9
  • 10Ahmed A, Gambassi G, Weaver MT, et al. Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure[J]. Am J Cardiol, 2007,100(2) :280.

二级参考文献24

共引文献33

同被引文献106

引证文献14

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部